Delsys, with its slogan "Shaping the Future of Human Sensing," has established itself as a leader in the hardware, manufacturing, and medical devices industries since its inception in 1993. Headquartered in the United States, the company specializes in designing and manufacturing high-performance electromyography (EMG) instruments alongside a range of physiological and biomechanical sensors crucial for movement measurement studies in research and education.
Delsys boasts a distinguished product portfolio that includes wired and wireless physiological sensors, amplifiers, and software solutions. Their patented parallel-bar sEMG sensors are notable for significantly minimizing signal artifacts and cross-talk, thereby enhancing the reliability and consistency of measurements under varied conditions. Such innovations are pivotal to thousands of researchers and educators in over 85 countries who tackle movement disorder challenges.
Despite its long-standing presence and robust market engagement, Delsys has not reported any recent investments, potentially highlighting an opportunity for investors to engage with a mature entity with proven market penetration and specialized expertise.